ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
INVESCO PHARMACEUTICALS ETF
124.70
+0.9400
0.76%
成交量:
2.59萬
成交額:
323.37萬
市值:
5.45億
市盈率:
6.47
高:
125.26
開:
124.72
低:
124.31
收:
123.76
52周最高:
131.68
52周最低:
90.01
股本:
437.00萬
流通股本:
437.00萬
量比:
1.36
換手率:
0.59%
股息:
1.06
股息率:
0.85%
每股收益(TTM):
19.29
每股收益(LYR):
21.73
淨資產收益率:
23.89%
總資產收益率:
0.60%
市淨率:
1.64
市盈率(LYR):
5.74
資料載入中...
總覽
公司
新聞資訊
公告
強生(JNJ)漲1.63% 新款雙周拋隱形眼鏡獲CE認證
金吾财讯
·
09/10
118款生物藥專利懸崖將至,中國藥企業迎戰MNC最大專利懸崖
蓝鲸财经
·
09/10
又爆了!集體飆漲!中東,再傳重磅
同花顺
·
09/10
艾伯維高管:穩健資產負債表與長期成長空間並存,公司可兼顧早期及晚期業務拓展機會——電話會議實錄
美股速递
·
09/09
安進(AMGN)聯合療法III期臨床達主要終點
金吾财讯
·
09/09
安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率
格隆汇
·
09/09
市場風向標:安進股價遭受重創
投资观察
·
09/09
安進股價或創二十餘年來最大單日跌幅
投资观察
·
09/09
諾華公司一款降膽固醇藥物在臨床試驗中失敗,Royalty Pharma股價下跌
路透中文
·
09/09
安進(AMGN)股票9月8日盤中下跌8.33%:真相來了
TradingKey中文
·
09/08
BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華
路透中文
·
09/08
更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期
路透中文
·
09/08
安進股價下跌7%,創下自2025年6月以來最大單日跌幅。
智通财经
·
09/08
更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標
路透中文
·
09/08
安進Phase 3 Dellphi-305研究重大突破:總生存期獲益顯著優於度伐利尤單抗單藥治療
美股速递
·
09/08
Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善
美股速递
·
09/08
BMO下調安進及BioNTech評級至「與大市同步」
格隆汇
·
09/08
雅培Tactiflex™ Duo消融導管獲FDA批准,用於治療異常心律患者
美股速递
·
09/08
美股盤前|英特爾、甲骨文升逾4%;諾華重挫12%,IONIS下跌10%;阿斯麥新一代EUV光刻機獲台積電和三星使用承諾
老虎资讯综合
·
09/08
諾華試驗受挫且BMO下調評級,安進股價下跌
路透中文
·
09/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/PJP/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PJP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","market":"US","secType":"STK","nameCN":"INVESCO PHARMACEUTICALS ETF","latestPrice":124.7,"timestamp":1789588800000,"preClose":123.76,"halted":0,"volume":25887,"delay":0,"changeRate":0.00759534583063993,"floatShares":4370000,"shares":4370000,"eps":19.286062,"marketStatus":"盤前交易","change":0.94,"latestTime":"09-17 06:41:29 EDT","open":124.72,"high":125.26,"low":124.305,"amount":3233733.88623,"amplitude":0.007717,"askPrice":143.11,"askSize":100,"bidPrice":107.58,"bidSize":100,"shortable":3,"etf":1,"ttmEps":19.286062,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":124.7,"sharesOutstanding":3870000,"nav":123.80876,"aum":542282368.8,"dividendRate":0.0085,"bidAskSpread":0.000822,"postHourTrading":{"tag":"盘后","latestPrice":124.75,"preClose":124.7,"latestTime":"19:30 EDT","volume":116,"amount":14470.35,"timestamp":1789601402980,"change":0.05,"changeRate":0.000401,"amplitude":0.000401},"volumeRatio":1.3550565433028936,"impliedVol":0.1594,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","floatShares":4370000,"roa":"0.60%","roe":"23.89%","lyrEps":21.734944,"volumeRatio":1.3550565433028936,"shares":4370000,"dividePrice":1.06,"high":125.26,"amplitude":0.007717,"preClose":123.76,"low":124.305,"week52Low":90.01,"pbRate":"1.64","psRate":"107.51","week52High":131.675,"institutionHeld":0.824,"latestPrice":124.7,"eps":19.286062,"divideRate":0.0085,"volume":25887,"delay":0,"ttmEps":19.286062,"open":124.72,"prevYearClose":104.54,"prevWeekClose":124.09,"prevMonthClose":127.49,"prevQuarterClose":118.4468,"fiveDayClose":126.2527,"twentyDayClose":127.8891,"sixtyDayClose":112.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PJP\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PJP","amount":0.27334,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PJP","amount":0.30902,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PJP","amount":0.24629,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PJP","amount":0.23633,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PJP","amount":0.26679,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PJP\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.10701,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.20736,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.03683,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.15586,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-29","value":0.12281,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PJP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PJP\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666596063","title":"強生(JNJ)漲1.63% 新款雙周拋隱形眼鏡獲CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596063","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:21","pubTimestamp":1789046500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生(JNJ)美股盘前股价震荡上行,最新涨1.63%,报271.4美元。消息面上,强生周四宣布,旗下新款ACUVUE OASYS MAX双周抛复用隐形眼镜已拿到CE认证。该款产品属于ACUVUE OASYS MAX产品线的新品,可在完整14天佩戴周期内保障佩戴舒适度与清晰视力。镜片搭载OptiBlue滤光技术、TearStable锁泪技术以及一类紫外线防护功能,专门面向长时间使用电子屏幕人群的用眼需求设计。上市节奏方面,计划2026年晚些时候率先登陆部分欧洲国家;后续视各地监管审批进度,在2027-2028年进一步拓展市场。目前该产品尚未取得美国FDA批准,暂未在美国市场销售。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305910","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","IXJ","BK4581","JDOC","IE00BGHQF631.EUR","LU2750360997.AUD","LU1228905037.USD","PJP","LU0964807845.USD","IE00BDGV0183.EUR","VHT","LU1291159041.SGD","LU0345770993.USD","LU2750360641.GBP","FHLC","XLV","JNJ","BK4592","LU1732800096.USD","IHE","LU0124676726.USD","IE00BLSP4239.USD","LU1043141396.HKD","IE00BVYPNW00.USD","LU2756315664.SGD","LU2756315318.SGD","LU0792757196.USD","LU0070217475.USD","BMED","BK4559","GDOC","IE00BN8TJ469.HKD","SG9999001440.SGD","LU0689626769.HKD","LU1244550494.USD","LU2505996509.AUD","LU0820562030.AUD","FTXH","LU0820561909.HKD","TRUH","LU0345770308.USD","LU2133065610.SGD","MEDX","LU1929549753.HKD","BK4532","IYH","LU2456880835.USD","RXL","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物藥專利懸崖將至,中國藥企業迎戰MNC最大專利懸崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出,未来几年全球MNC将迎来史上最大专利悬崖,有118种生物制剂将会失去相应的专利保护,涉及2340亿美元市场。然而,目前这118款即将到期分子中,只有极少数在火热开发,大量缺口有待生物类似药填补。目前来说,创新药出海还没办法完成这个闭环,但生物类似药作为先头部队做出海试验,企业风险和获益会更高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["FXH","PBPH","PJP","IHE","TMED","TRUH","BBP","159839","RSPH","MEDI","APXH","BME","JDOC","IYH","BBH","PPH","GSKH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666528665","title":"又爆了!集體飆漲!中東,再傳重磅","url":"https://stock-news.laohu8.com/highlight/detail?id=2666528665","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666528665?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:37","pubTimestamp":1789011420,"startTime":"0","endTime":"0","summary":"中午好,在本周二大涨之后,能化板块又爆发了!周四早盘,原油期货主力合约一度涨近10%,纯苯、苯乙烯期货主力合约涨停。截至11:30收盘,原油期货主力合约涨幅有所收窄,纯苯期货主力合约涨 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260910/c679776426.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260910/c679776426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4581","TBXU","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4588","IE00B2B36J28.USD","LU1571399168.USD","BK4139","AMGN","LU2468319806.SGD","LU0868494617.USD","BK4566","LU1061106388.HKD","LU0058720904.USD","IBB","BK4585","LU0320765992.SGD","BIB","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","IBBQ","IE0002141913.USD","PJP","BK4533","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4599","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","PBE","SG9999001440.SGD","LU0109394709.USD","LU2242646821.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4534","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191303955","title":"艾伯維高管:穩健資產負債表與長期成長空間並存,公司可兼顧早期及晚期業務拓展機會——電話會議實錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1191303955","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191303955?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:56","pubTimestamp":1788965760,"startTime":"0","endTime":"0","summary":"在近日一场备受关注的电话会议中,艾伯维公司高管明确表示,凭借其稳健的资产负债表以及充裕的长期增长跑道,公司目前能够同时审视并把握早期与晚期阶段的业务拓展契机。这一表态暗示,这家制药巨头在战略布局上拥有充分的灵活性与多元选择空间,既可着眼于处于萌芽阶段的创新资产,亦不排除对相对成熟项目的果断介入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU1244550577.SGD","LU0289739699.SGD","LU0234572021.USD","LU0310800379.SGD","LU1989772923.USD","IXJ","LU2237443895.HKD","LU0456855351.SGD","IE0002270589.USD","LU1934455277.USD","IE0004445239.USD","LU2129689514.USD","SG9999015945.SGD","BK4550","XLV","LU0211328371.USD","LU1291159041.SGD","LU1430594728.SGD","LU0545039389.USD","LU1244550494.USD","IE00B2B36J28.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU2087621335.USD","IE000BZT7R73.USD","LU0289961442.SGD","LU0965509010.AUD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU1923622614.USD","RXL","LU0912757837.SGD","LU2133065610.SGD","IE00BLSP4452.SGD","BK4581","IE0002141913.USD","LU0417517546.SGD","LU0689626769.HKD","MEDX","BK4585","LU1496350502.SGD","IE000WAW04H5.SGD","LU2237443465.HKD","LU0511384066.AUD","LU0820561818.USD","VHT","LU0256863902.USD","LU0058720904.USD","LU1983299246.USD","LU0432979614.USD","BK4566","LU0203347892.USD","LU1732799900.SGD","BK4534","LU1839511570.USD","LU0553294199.USD","LU0158827948.USD","LU0128525929.USD","LU0795875086.SGD","LU1718418525.SGD","LU1989771016.USD","LU2089283258.USD","LU0795875169.SGD","LU0472753341.HKD","LU2347655073.USD","LU0203345920.USD","LU0823416689.USD","LU0256863811.USD","IE00BLSP4239.USD","SG9999015978.USD","IE000SO60NU8.SGD","IE00B4R5TH58.HKD","LU0320765646.SGD","LU1023059063.AUD","AGNG","LU0868494708.USD","LU0942090050.USD","LU2125909247.SGD","LU1236620750.USD","JDOC","SG9999015952.SGD","SG9999011175.SGD","IE0000B7K699.USD","IE00BN8TJ469.HKD","GLAM","LU0708994859.HKD","LU0124676726.USD","LU1496350171.SGD","BK4559","BK4588","LU2237443382.USD","LU0310799852.SGD","LU0868494617.USD","LU0943347566.SGD","LU1934455194.USD","LU1267930490.SGD","LU1162221912.USD","PPH","IE00B3PB1722.GBP","LU2347655156.SGD","LU1732800096.USD","LU0289739343.SGD","LU2125909593.SGD","LU1934455863.HKD","LU0965509101.SGD","LU2129689605.HKD","LU2089284900.SGD","LU1929549753.HKD","LU2468319806.SGD","IE00BSNM7G36.USD","BK4533","LU0820561909.HKD","IE0009355771.USD","IE000MB6IJN5.SGD","LU1074936037.SGD","IE00BDGV0183.EUR","LU1061106388.HKD","SG9999015986.USD","LU1093756325.SGD","LU0861579265.USD","LU0726765562.USD","LU1093756168.USD","LU2112291526.USD","IE00BGHQF631.EUR","IE00B19Z3B42.SGD","LU2237443549.SGD","FTXH","LU0395794307.EUR","LU1003077747.HKD","LU1057294990.SGD","LU0985320562.USD","LU1244550221.USD","LU0069063385.USD","IE00BJJMRZ35.SGD","LU1267930573.SGD","LU0114720955.EUR","LU0098860793.USD","LU1037948897.HKD","IE00B19Z3581.USD","LU2237443622.USD","LU2129689431.USD","LU0170899867.USD","FHLC","LU1670628061.USD","LU0859254822.USD","LU0965509283.SGD","IE00BVYPNV92.GBP","ABBV","LU0882574055.USD","LU0738911758.USD","LU1037948541.HKD","LU2433249047.HKD","PJP","LU0234570918.USD","LU1236620834.HKD","LU0122379950.USD","LU1989772840.SGD","LU1551013425.SGD","SG9999001440.SGD","TRUH","LU0198837287.USD","IE00BJT1NW94.SGD","LU1670627923.USD","IE000F7OJYX1.SGD","IYH","LU0029864427.USD","LU0211327993.USD","LU2089984988.USD","LU2357627491.SGD","SG9999003800.SGD","LU2237443978.SGD","LU0661504455.SGD","LU1551013342.USD","IE00BVYPNW00.USD","LU0965508806.USD","BK4139","LU0949170772.SGD","LU0057025933.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666712586","title":"安進(AMGN)聯合療法III期臨床達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712586","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666712586?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 16:59","pubTimestamp":1788944360,"startTime":"0","endTime":"0","summary":"金吾财经 | 安进公布,双特异性T细胞衔接器Imdelltra联合阿斯利康PD-L1抑制剂英飞凡,在广泛期小细胞肺癌的后期临床试验中实现总生存期延长。这家加州生物制药企业披露III期DeLLphi-305研究中期数据,该试验达成广泛期小细胞肺癌患者总生存期主要终点。该项全球试验评估该组合作为一线维持治疗,受试者既往接受过包含英飞凡的治疗且病情未发生进展。研究同时达成无进展生存期、客观缓解率两项次要终点。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0029864427.USD","IE0002141913.USD","LU0289739699.SGD","BK4568","BK4585","BK4566","LU0128525929.USD","TBXU","LU1267930573.SGD","BBH","IE00B4R5TH58.HKD","LU2112291526.USD","LU2237443895.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","BIB","LU2456880835.USD","LU0708994859.HKD","LU0058720904.USD","LU0868494617.USD","BK4599","BK4139","LU2242646821.SGD","LU2468319806.SGD","IBBQ","LU1829250122.USD","LU2237443382.USD","LU1023059063.AUD","LU2462157665.USD","PJP","BK4533","IE00BFTCPJ56.SGD","LU1571399168.USD","AZN","AZNH","LU0889565916.HKD","LU0122379950.USD","IBB","BK4534","LU0432979614.USD","LU2236285917.USD","LU2242652126.USD","PBE","IE00B2B36J28.USD","LU2237443622.USD","AMGN","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309213","title":"安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309213","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309213?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 10:39","pubTimestamp":1788921579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","PSYK","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","MDTX","LU0868494617.USD","LU0320765992.SGD","BMED","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","IBBJ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112638879","title":"市場風向標:安進股價遭受重創","url":"https://stock-news.laohu8.com/highlight/detail?id=1112638879","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112638879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:35","pubTimestamp":1788903338,"startTime":"0","endTime":"0","summary":"“这对安进而言,堪称最糟糕的结局。”——巴克莱分析师艾米丽·菲尔德如此评价。此前,诺华制药公布了其心脏病药物令人失望的试验结果,这一披露不仅让诺华自身承压,更给安进旗下一款重磅药物蒙上了厚厚的阴影。","market":"hk","thumbnail":"https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IBB","IE00B2B36J28.USD","BK4139","LU2468319806.SGD","TBXU","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4599","LU0320765992.SGD","LU2112291526.USD","LU0868494617.USD","IE0002141913.USD","BK4534","BK4566","LU1983299246.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4533","LU0122379950.USD","BIB","BK4581","SG9999001440.SGD","PBE","LU1571399168.USD","BK4588","LU1061106388.HKD","LU0289739699.SGD","LU0058720904.USD","IBBQ","BK4585","LU0889565916.HKD","LU1023059063.AUD","PJP","IE00BJJMRZ35.SGD","BBH","IE00BFTCPJ56.SGD","AMGN","LU2242652126.USD","LU1057294990.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安進股價或創二十餘年來最大單日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111756325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%,这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索,源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂,试验宣告失败。周二,礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧,使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"hk","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","04332","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗,Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅,该股今年以来累计上涨54.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","RPRX","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","BK4007","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IONS","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%:真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败,加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧,BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示,安进的 RSI 为 40.256,威廉指标(Williams %R)为 97.857。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串:STXBZ《今日展望》通讯:https://refini.tv/3LI4BU7《晨间新闻简报》:https://refini.tv/3dKUyB8路透9月8日-周二开盘时,华尔街主要股指涨跌不一,中东地区新一轮冲突推动油价升至7月下旬以来的最高水平,而市场正在等待本周晚些时候","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LU0011850046.USD","IONL","LU1989772923.USD","LU2362540622.SGD","BK4533","BK4597","LU1057294990.SGD","LU2506952097.USD","SGML","IE00BLSP4452.SGD","LU0170899867.USD","ICLN","LU0029874061.USD","LU0444973449.USD","LU1861558580.USD","LU0266013472.USD","PTH","SEI","WQTM","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","PJP","IOYY","LU0138981039.USD","LU0868494617.USD","LU1861559042.SGD","BK4170","BEZ","LU1989771016.USD","LU0122379950.USD","LU0225284248.USD","SG9999003800.SGD","SGXZ57979304.SGD","SRPT","BK4581","LU1791710582.SGD","LU2242652126.USD","PFE","LU1303367103.USD","BEC","LU1815336760.USD","LU0225283273.USD","IE0009354923.USD","LU1791710400.SGD","HYDR","LU0889565916.HKD","LU2244417387.USD","IE00B66KJ199.SGD","BK4556","QTUP","BK4548","LU0058720904.USD","BK4602","IE00B19Z4B17.USD","LU0823417737.USD","BK4592","IE00B3T34201.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","ABM","LU2089984988.USD","WATS","MEDX","BK4120","CQTM","BK4591","BK4541","IE0031619046.USD","BK4121","IE0009355771.USD","LU0957808578.USD","SG9999011175.SGD","BK4124","LU0528227936.USD","PBE","SG9999001440.SGD","SMOG","LU1066053197.SGD","GNMX","BK4007","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2506951792.HKD","LU0187121727.USD","LU1989764748.USD","LU0114720955.EUR","RGTU","IONZ","LU1291159041.SGD","BK4568","CNRG","LU2112291526.USD","LU2362541513.USD","IE00BLSP4239.USD","LU2506952170.USD","RGTI","SG9999002232.USD","TBXU","BE","BEX","LU0444971666.USD","LU1366192091.USD","IE0002141913.USD","IONS","LU2357125470.USD","LU0208291251.USD","LU0456855351.SGD","CHRW","LU1989764664.SGD","IE000M9KFDE8.USD","LU2242649171.HKD","BEG","LU0353189763.USD","LU0345769631.USD","LU1894683264.USD","IBBQ","LU0109394709.USD","EGGY","LU0823414478.USD","OIH","IE0002270589.USD","LU1894683348.USD","IE00B2B36J28.USD","04332","LU1548497426.USD","LU1804176565.USD","LU1988902786.USD","LU0070302665.USD","BK4532","LU0878866978.SGD","LU2468319806.SGD","LU2294711713.HKD","LU1642822529.SGD","LU2543165471.USD","LU2596442595.SGD","ZAP","UPGR","BK4534","LU0950375773.USD","BK4504","LU0433182093.SGD","IBB","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","IONQ","BK4139","LU0823416689.USD","BK4535","LU2087625088.SGD","IONX","LU0882574055.USD","PHVS","LU0267386448.USD","GNOM","BSX","LU1571399168.USD","LU1983299246.USD","SG9999001176.USD","LU2264538146.SGD","LU2098885051.SGD","LU0432979614.USD","LU1153585028.USD","LU0823414551.USD","LU1093756325.SGD","BBH","BK4182","LU0321505439.SGD","LU1023059063.AUD","RGYY","VCLN","LU0068578508.USD","LU0823417653.USD","LU1093756168.USD","BK4550","LU2265009873.SGD","LU2242646821.SGD","BK4505","CTEC","LU1883839398.USD","RGTZ","LU2324357040.USD","LU0306806265.USD","UNFI","BK4168","LU0345769128.USD","LU0128526141.USD","DYN","LU0306807586.USD","BK4082","AMGN","LU2491049909.HKD","VTWG","IE00B19Z3581.USD","ALV","SRPU","LU1064131342.USD","BK4567","IONC","ILMN","IE0034235188.USD","LU0320765489.SGD","BIB","BK4179","LU0048584097.USD","LU2506951958.HKD","LU2491050071.SGD","LU0353189680.USD","LU2491050154.USD","LU2249611893.SGD","NVS","RGTX","BK4141","BK4588","IE00BFTCPJ56.SGD","LU0238689110.USD","ROIV","RGTC","LU1061106388.HKD","LU0234572021.USD","SHAK","LU0985481810.HKD","LU0289739699.SGD","LU1489326972.SGD","BK4209","BK4131","LU2362541273.HKD","SG9999001176.SGD","LU0320765992.SGD","SIMS","BHVN","IBAT","LU0077335932.USD","LU0251132253.USD","LU0476273544.USD","LU1718418525.SGD","LU2357305700.SGD","BK4578","SG9999002224.SGD","LU0211331839.USD","LU2506951875.HKD","NTLA","OZEM","USNG","BK4599","LU0321505868.SGD","PPH","XES","BK4566","LU1989772840.SGD","BK4102","FRNW","LU0225771236.USD","LU1878469433.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示,其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用,在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半;2025年,在该公司256.2亿美元的肿瘤产品收入中,Imfinzi贡献了60.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0171293334.USD","BIB","LU1046234339.USD","LU0058720904.USD","LU1273509221.SGD","LU0557290698.USD","LU0887340254.USD","IBB","LU0029864427.USD","BBH","IE0009355771.USD","LU2108987350.USD","AZN.UK","LU0211328371.USD","LU0997586432.USD","LU2279689827.SGD","LU1989771016.USD","LU0158827948.USD","IE00B3T34201.USD","LU0708994859.HKD","LU1267930490.SGD","LU2089284900.SGD","BK4588","LU0889566641.SGD","LU0969580561.USD","LU1196032939.SGD","BK4585","LU0784384876.USD","LU2237443622.USD","LU2242646821.SGD","LU1153585028.USD","LU0211327993.USD","IBBQ","BK4533","PBE","AMGN","LU1267930813.SGD","LU0289739699.SGD","TBXU","LU0211326755.USD","LU0553294199.USD","LU2468319806.SGD","03165","LU0738911758.USD","PJP","LU1267930227.SGD","LU2125909593.SGD","LU0792757196.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%,創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1023059063.AUD","IBBQ","AMGN","LU0889565916.HKD","BK4588","LU0320765992.SGD","IBB","LU0868494617.USD","LU0058720904.USD","BK4139","PBE","BK4533","BIB","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0009355771.USD","BK4566","LU0109394709.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1571399168.USD","TBXU","BBH","LU2242652126.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732793","title":"更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732793","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732793?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873260,"startTime":"0","endTime":"0","summary":"阿斯利康抗癌药物组合在晚期临床试验中达到主要生存目标路透9月8日-阿斯利康(AstraZeneca)AZN.L周二表示,其抗癌药物Imfinzi与安进(Amgen)的AMGN.O靶向免疫疗法Imdelltra联合使用,在一项晚期临床试验中,显著提高了广泛期小细胞肺癌一线治疗患者的总生存期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S450114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","BK4599","LU0997586515.USD","LU2237443465.HKD","LU0029864427.USD","LU0920783379.SGD","AZN.UK","BK4139","LU0058720904.USD","LU0122379950.USD","LU1863844749.USD","LU2091194634.USD","LU1084165304.USD","IBBQ","BIB","LU0545039389.USD","LU1487256676.USD","LU1829250122.USD","IBB","IE0034235188.USD","LU0957799991.USD","LU1061106388.HKD","LU0077335932.USD","LU1003076772.USD","LU0526926950.USD","LU1880407132.USD","AMGN","LU0969580561.USD","LU0203347892.USD","PBE","LU1023059063.AUD","TBXU","LU0109394709.USD","03165","LU0784383803.USD","LU0868494617.USD","LU0289739699.SGD","LU1046234339.USD","PJP","LU2279689827.SGD","LU2355687059.USD","LU0889566641.SGD","LU2433249047.HKD","LU1170363599.USD","LU0827474353.SGD","LU2242652126.USD","LU1923622614.USD","LU1481599808.USD","BBH","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安進Phase 3 Dellphi-305研究重大突破:總生存期獲益顯著優於度伐利尤單抗單藥治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115495471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布,其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比,该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现,无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露,但安进方面表示,其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进,安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","PBE","BK4588","LU0122379950.USD","TBXU","IE00B4R5TH58.HKD","AMGN","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","LU1061106388.HKD","IE0002141913.USD","SG9999001440.SGD","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","BK4533","BIB","BK4599","IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","BBH","LU2089984988.USD","LU1983299246.USD","BK4581","LU0889565916.HKD","BK4534","LU2242652126.USD","LU0320765992.SGD","BK4566","PJP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109517247?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法,于一线广泛期小细胞肺癌治疗领域,取得了具有划时代意义的总生存期提升。这一突破性进展,不仅为患者带来了新的曙光,也重塑了该领域的治疗格局。从数据层面观察,联合治疗方案的生存获益尤为显著,堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","AMGN","LU1061106388.HKD","LU2242646821.SGD","BK4566","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2468319806.SGD","IBB","BK4533","LU0122379950.USD","IE00B2B36J28.USD","BK4139","LU0868494617.USD","LU1983299246.USD","BK4588","LU2112291526.USD","IE0002141913.USD","LU2242652126.USD","BBH","IBBQ","BK4581","IE0009355771.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU0289739699.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","LU2089984988.USD","PBE","LU0109394709.USD","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189262773","title":"雅培Tactiflex™ Duo消融導管獲FDA批准,用於治療異常心律患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1189262773","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189262773?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868911,"startTime":"0","endTime":"0","summary":"雅培近日宣布,其研发的Tactiflex Duo消融导管已获得美国食品药品监督管理局的正式批准。Tactiflex Duo消融导管融合了先进的传感技术与灵活操控性能,能够在手术过程中实现更稳定的组织接触和更精确的能量传递,从而有效消除引发心律失常的异常电信号源。雅培相关业务负责人表示,该导管的获批基于多项严格临床试验的积极数据,证实了其在安全性和有效性方面的卓越表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","LU1670628061.USD","SG9999002232.USD","BK4504","LU0868494617.USD","LU0266013472.USD","LU1023059063.AUD","LU1057294990.SGD","LU0208291251.USD","LU1721429741.USD","LU2112291526.USD","LU0122379950.USD","LU0432979614.USD","LU2324357040.USD","PJP","BK4533","IE0009355771.USD","LU1670627923.USD","LU1914381329.SGD","LU0320765489.SGD","LU0289739699.SGD","LU1989763427.SGD","SG9999002224.SGD","BK4566","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4568","LU0211331839.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0234572021.USD","LU2211815571.USD","BK4585","LU0882574055.USD","LU0058720904.USD","LU2468319806.SGD","LU0170899867.USD","LU0114720955.EUR","LU1721429402.USD","BK4592","TMED","ABT","LU1061106388.HKD","SG9999004303.SGD","IHI","SGXZ41872573.SGD","BK4588","IE00BJJMRZ35.SGD","LU0070302665.USD","LU2133065610.SGD","SGXZ23171101.USD","IE0002141913.USD","LU1983299246.USD","LU1989763690.USD","BK4082","LU2237957811.SGD","LU2237957902.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前|英特爾、甲骨文升逾4%;諾華重挫12%,IONIS下跌10%;阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%,报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备,并与ASML签订光罩尺寸升级合作协议,助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","LU0823417653.USD","LU0056508442.USD","LU0541501648.USD","LU1093756325.SGD","OZEM","BK4141","LU0976567544.SGD","LU1069347547.HKD","LU2505996509.AUD","IE0004086264.USD","LU1804176565.USD","IGV","LU0070217475.USD","LU1983299246.USD","LU1150488218.USD","CGDG","LU0950375773.USD","LU2129689431.USD","LU0359202008.SGD","LU0889566641.SGD","LU0124676726.USD","LU0278409577.USD","SG9999013999.USD","LU2125154935.USD","BK4548","LU2087621335.USD","SGXZ57979304.SGD","BK4599","LU0061474960.USD","IE00BLSP4452.SGD","LU0345774391.USD","IE00BHPRN162.USD","LU1718418525.SGD","BK4535","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","LU2129689514.USD","LU0868494617.USD","IE00B19Z3581.USD","EFA","BK4526","LU2089283258.USD","LU2362541513.USD","LU2543165471.USD","IE00BQXX3C00.GBP","TTEQ","FDTX","LU2458330243.SGD","LU2360108059.USD","LU0868494708.USD","BK4566","SG9999001440.SGD","LU2023250504.SGD","LU2506951958.HKD","AIQ","LU0878005551.USD","LU0289739699.SGD","LU1803068979.SGD","SG9999014575.USD","XLE","BK4201","DDM","LU0130103400.USD","LU0823434583.USD","LU1064131342.USD","BBH","LUMA","LU2491050154.USD","LU1366192091.USD","LU2764262908.HKD","LU0300736062.USD","LU1989772923.USD","LU1585245621.USD","LU1778281490.HKD","FTXL","LU1066053197.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU0823416689.USD","LU1282649067.USD","QQQA","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","LU1894683348.USD","LU2430703251.USD","LU0654597011.USD","LEGR","LU2264538146.SGD","LU0545039389.USD","LU0081259029.USD","WEEI","BK4503","LU1868838027.USD","LU1992135472.HKD","LU1935042488.USD","PPH","LU0572939691.SGD","LU0345770993.USD","LU1282649810.SGD","INTW","LU2362540622.SGD","SPTE","BK4570","LU0368265418.SGD","LU1023057109.AUD","LU2211814178.USD","LU0211327993.USD","LU0965509101.SGD","LU2237443549.SGD","LU0476273544.USD","LU0122379950.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","BK4528","IE00BQXX3F31.USD","LU1974910355.USD","BK5113","BK4007","PXI","IE00BFXG1179.USD","LU2063271972.USD","TRUN","AVEM","LU0238689110.USD","IE000SO60NU8.SGD","BK4097","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU0162691827.USD","LU2896262040.SGD","WQTM","LU0256863811.USD","LU0143863784.USD","LU2244417387.USD","LU0048573561.USD","SG9999000418.SGD","LU2487616109.SGD","LU0070302665.USD","LU1935043536.SGD","LU1046421795.USD","LU0957791311.USD","LU0251132253.USD","IE00BN8TJ469.HKD","IYE","EPAI","LU0345769631.USD","LU0444973449.USD","IXC","IE00BBT3K403.USD","LU1989764748.USD","LU2764263203.CNY","LU0466842654.USD","LU1267930227.SGD","LU0094547139.USD","CRAK","BK4534","BK4516","BLOX","BK4148",".DJI","LU2324357040.USD","LU1917777945.USD","ASIA","INT","LU1791710582.SGD","LU2505996681.GBP","LU0210528500.USD","IE00B7SZL793.SGD","QTUP","LU2473716301.USD","LU1861215975.USD","LU1435385759.SGD","LU2271345857.HKD","LU0738911758.USD","LU0882574055.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","LU0553294199.USD","BK4532","LU1815336760.USD","IE00B19Z4B17.USD","LU0742534661.SGD","LU2471134879.HKD","OILT","LU2089984988.USD","LU1582986359.USD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","ASMH","LU0496365809.HKD","BK4023","ERX","LU0274383776.USD","DBEF","LU2360106780.USD","LU1489326972.SGD","IE00BZ1G4Q59.USD","TDIV","IBBQ","IE00B5949003.HKD","LU0314106906.USD","LU0114720955.EUR","LU0143863198.USD","IE00BFXG0V08.USD","PQNT","LU0097036916.USD","LU0149725797.USD","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","ORCU","LU0109394709.USD","LU2491049909.HKD","LU0648000940.SGD","CGNG","LU0072461881.USD","LU0208291251.USD","LU0266512127.USD","BK4504","LU0321505439.SGD","LU0157215616.USD","LU0823038988.USD","LU1935043023.USD","RSPG","DRIV","LU0942090050.USD","LU1929549753.HKD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","IFLR","LU2360107168.USD","LU1935042215.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","LU0052756011.USD","LU0985489474.SGD","LU2720916845.USD","VDE","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU0084288322.USD","BIB","LU1150488135.SGD","SMH","CTEX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","BK4170","LU2430703178.SGD","LU2236285917.USD","LU0211328371.USD","LU2592432038.USD","LU1674673428.USD","LU2663582299.SGD","SPWO","HYDR","LU0541502299.USD","LU1674673691.USD","LU2111349929.HKD","LU2148611432.USD","IE00BD6J9T35.USD","LU0068578508.USD","LU2471134796.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU0138981039.USD","AVXC","CNAV","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2750360641.GBP","BK4157","LU1894683264.USD","FENI","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","LU0868486357.SGD","LU0823039010.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2506951875.HKD","OGIG","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2326559502.SGD","IE000BZT7R73.USD","TEK","LU1023059063.AUD","GNMX","LU0320765992.SGD","LU0058720904.USD","03165","LU1582987597.SGD","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","IE00B1XK9C88.USD","IE0002270589.USD","LU0128525689.USD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1989771016.USD","SG9999004220.SGD","SG9999002224.SGD","LU1720051017.SGD","IEO","LU1066051498.USD","LU0612318385.USD","LU0300736492.USD","SPY","LU2250418816.HKD","IE00B775SV38.USD","IE000WAW04H5.SGD","LU2028103732.USD","IE00BLSP4239.USD","LU1429558221.USD","LU0175139822.USD","LU0154245673.USD","LU0823421416.USD","LU0029874061.USD","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","LU2272731782.SGD","LU2087625088.SGD","GXPE","SGXZ81514606.USD","LU0289960550.SGD","LU0264606111.USD","BK7095","BK4533","LU0154236417.USD","LU0878004406.USD","LU1057294990.SGD","ILOW","LU2054465674.USD","LU2237443382.USD","BK4538","LU1201861165.SGD","IE0009356076.USD","IE0031619046.USD","IE000MB6IJN5.SGD","DOG","LU2746668461.USD","LU1506573853.SGD","LU2764263039.SGD","BK4121","ORCX","AIS","FENY","LU1074936037.SGD","IEFA","SG9999011175.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","DRLL","LU2602419157.SGD","BK4529","DIG","LU1989764664.SGD","IBB","HK0000304797.USD","LU0267386448.USD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU2471134523.USD","LU0321505868.SGD","BK4559","IE00B1BXHZ80.USD","IE00B2Q91V27.USD","LU2506952170.USD","IE0004445239.USD","LU0384037296.USD","THNR","LU0683600562.USD","LU2290526834.HKD","ORCL","LU1316542783.SGD","CQTM","LU0788109394.HKD","LU1548497426.USD","ORAC","BK4505","EGGY","LU1823568750.SGD","TINS","LU0433182093.SGD","DIA","WUGI","LU0488056044.USD","MEMX","DBEU","LU0234572021.USD","LU1720051108.HKD","FOTO","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LINT","AVSE","BK4213","BK4605","BGIA","TEXU","LU0965509283.SGD","LU0320765489.SGD","IE0004091025.USD","PBE","BK4591","LU0612318971.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU0211326755.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","BK4608","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","PXE","LU2322448957.HKD","LU0130517989.USD","BK4543","LU0256331488.USD","LU0353189763.USD","LU1868837722.USD","LU2462591277.SGD","LU0359201885.HKD","LU1691799644.USD","LU0310800965.SGD","FTXN","IE0000B7K699.USD","BK4527","LU1861220033.SGD","LU0320765646.SGD","SG9999015358.SGD","BK4588","NVS","INYY","LU0353189680.USD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","IGE","ORCS","SG9999001176.SGD","LU2237443978.SGD","IE00B3CCJ963.GBP","LU1582987324.SGD","LU1582986433.USD","LU0889565833.HKD","GNOM","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","TBXU","LU1430594728.SGD","LU1061106388.HKD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","SG9999003800.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU0431992006.USD","LU2294711713.HKD","LU0648001328.SGD","LU1048588211.SGD","LU2506952097.USD","SG9999001424.SGD","SDOW","LU0053666078.USD","BK4602","UDOW","LU0143551892.USD","LU0154245756.USD","CGIC","TNGY","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","LU0477156953.USD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU2362541273.HKD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","LU2242646821.SGD","BK4592","LU2272731600.USD","LU2242652126.USD","LU0122376428.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2237957902.USD","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","XNTK","LU0323591593.USD","LU2112291526.USD","LU0792757196.USD","LU2347655156.SGD","SG9999001176.USD","LU1992135399.USD","LU2133065610.SGD","SPRX","LU1430597077.USD","LU0203347892.USD","FFGX","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","INTC","LU1267930490.SGD","FCG","LU0661504455.SGD","LU1235294995.USD","LU2129689605.HKD","BK4612","LU0980610538.SGD","BK4082","LU1162221912.USD","BAI","LU0823421333.USD","LU1852331112.SGD","LU1623119135.USD","LU1734074674.USD","LU0949170772.SGD","LU0048584097.USD","IE00BGHQF524.EUR","LU0345774631.USD","LU0251142724.SGD","LU0266512473.USD","LU0823417737.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","LU0128526141.USD","GSID","BK4147","UMMA","BK4515","LU0823434740.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2249611893.SGD","LU0158827948.USD","BK7104","LU2458330169.SGD","LU1035773651.USD","IE00BSNM7G36.USD","BK4579","LU2357125470.USD","LU1988902786.USD","LU2089985449.USD","BK4139","KNOW","LU0444971666.USD","LU0211326839.USD","LU2298321311.HKD","LU2750360997.AUD","CORO","LU1839511570.USD","LU2237957811.SGD","LU2468319806.SGD","LU0528227936.USD","LU1291159041.SGD","LU0130102774.USD","LU0266013472.USD","LU0251131958.USD","BK4138","BK4585","CWI","LU0912757837.SGD","LU0310799852.SGD","LU0345780950.USD","LU0878866978.SGD","ORCZ","IE00B5TLWC47.USD","IE000F7OJYX1.SGD","IE00B66KJ199.SGD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級,安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级,安进股价下跌9月8日-** 安进公司(AMGN.O)股价盘前下跌4.8%,至416美元** 诺华公司(NOVN.S)的降胆固醇药物在一项备受关注的研究中未能达标,这引发了市场对安进公司(Amgen)实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示,诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期,而该","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0868494617.USD","LU0320765992.SGD","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}